Detalles de la búsqueda
1.
Sex-related differences in serum biomarker levels predict the activity and efficacy of immune checkpoint inhibitors in advanced melanoma and non-small cell lung cancer patients.
J Transl Med
; 22(1): 242, 2024 Mar 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-38443899
2.
Molecular Modeling Unveils the Effective Interaction of B-RAF Inhibitors with Rare B-RAF Insertion Variants.
Int J Mol Sci
; 24(15)2023 Jul 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-37569660
3.
Basal and one-month differed neutrophil, lymphocyte and platelet values and their ratios strongly predict the efficacy of checkpoint inhibitors immunotherapy in patients with advanced BRAF wild-type melanoma.
J Transl Med
; 20(1): 159, 2022 04 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35382857
4.
Per- and polyfluoroalkyl substances (PFAS) exposure in melanoma patients: a retrospective study on prognosis and histological features.
Environ Health
; 21(1): 126, 2022 12 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-36482443
5.
Sex and interleukin-6 are prognostic factors for autoimmune toxicity following treatment with anti-CTLA4 blockade.
J Transl Med
; 16(1): 94, 2018 04 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-29642948
6.
Mitotic rate correlates with sentinel lymph node status and outcome in cutaneous melanoma greater than 1 millimeter in thickness: A multi-institutional study of 1524 cases.
J Am Acad Dermatol
; 76(2): 264-273.e2, 2017 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-27847125
7.
CASE STUDY ON AN IPILIMUMAB COST-CONTAINMENT STRATEGY IN AN ITALIAN HOSPITAL.
Int J Technol Assess Health Care
; 33(2): 199-205, 2017 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-28703084
8.
Consolidation electrochemotherapy with bleomycin in metastatic melanoma during treatment with dabrafenib.
Radiol Oncol
; 49(1): 71-4, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25810704
9.
Clinical experience with ipilimumab 3 mg/kg: real-world efficacy and safety data from an expanded access programme cohort.
J Transl Med
; 12: 116, 2014 May 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-24885479
10.
Efficacy and safety of ipilimumab in patients with advanced melanoma and brain metastases.
J Neurooncol
; 118(1): 109-16, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24532241
11.
A multiparameter liquid biopsy approach allows to track melanoma dynamics and identify early treatment resistance.
NPJ Precis Oncol
; 8(1): 78, 2024 Mar 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-38548846
12.
Adjuvant Therapy of Nivolumab Combined With Ipilimumab Versus Nivolumab Alone in Patients With Resected Stage IIIB-D or Stage IV Melanoma (CheckMate 915).
J Clin Oncol
; 41(3): 517-527, 2023 01 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-36162037
13.
Discontinuation of anti-PD1 in advanced melanoma: an observational retrospective study from the Italian Melanoma Intergroup.
Eur J Cancer
; 187: 25-35, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37099946
14.
Investigating the Retained Inhibitory Effect of Cobimetinib against p.P124L Mutated MEK1: A Combined Liquid Biopsy and in Silico Approach.
Cancers (Basel)
; 14(17)2022 Aug 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-36077693
15.
The immune cell landscape of metastatic uveal melanoma correlates with overall survival.
J Exp Clin Cancer Res
; 40(1): 154, 2021 May 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33947438
16.
No Impact of NRAS Mutation on Features of Primary and Metastatic Melanoma or on Outcomes of Checkpoint Inhibitor Immunotherapy: An Italian Melanoma Intergroup (IMI) Study.
Cancers (Basel)
; 13(3)2021 Jan 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-33530579
17.
Melanoma of Unknown Primary: Evaluation of the Characteristics, Treatment Strategies, Prognostic Factors in a Monocentric Retrospective Study.
Front Oncol
; 11: 627527, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33747946
18.
Corrigendum: Melanoma of Unknown Primary: Evaluation of the Characteristics, Treatment Strategies, Prognostic Factors in a Monocentric Retrospective Study.
Front Oncol
; 11: 686051, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33937089
19.
Corrigendum: Melanoma in Adolescents and Young Adults (AYA): Evaluation of the Characteristics, Treatment Strategies, and Prognostic Factors in a Monocentric Retrospective Study.
Front Oncol
; 11: 793169, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34778096
20.
Melanoma in Adolescents and Young Adults: Evaluation of the Characteristics, Treatment Strategies, and Prognostic Factors in a Monocentric Retrospective Study.
Front Oncol
; 11: 725523, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34604064